Your browser doesn't support javascript.
loading
Concomitant Gastric Malignancy and Hepatocellular Carcinoma.
Mathew, Reshmi; Churchill, Gregory; Cheema, Bakht; Desai, Ketav; Alkhasawneh, Ahmad; Liu, Shiguang; Siddiqi, Anwer.
Afiliação
  • Mathew R; Internal Medicine, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Churchill G; Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Cheema B; Gastroenterology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Desai K; Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Alkhasawneh A; Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Liu S; Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
  • Siddiqi A; Pathology, University of Florida College of Medicine - Jacksonville, Jacksonville, USA.
Cureus ; 14(6): e25607, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35686196
ABSTRACT
Multiple primary malignant tumors (MPMTs) are two or more separate malignancies found at different sites concurrently. Prior studies have shown that the most common tumor associations in MPMTs are typically between two tumors in the digestive system. We present a case of a male patient in his 60s who initially presented with melena and was found to have a clean-based gastric ulcer on initial endoscopic evaluation. Repeat endoscopy on later admission revealed persistent ulceration. Biopsy showed Epstein-Barr virus (EBV) positive lymphoepithelioma-like gastric carcinoma (LELGC), a rare gastric malignancy. The patient underwent endoscopic ultrasound (EUS) for assessment of tumor depth and involvement of perigastric lymph nodes, but was incidentally found to have a liver lesion. Biopsy of the liver lesion was positive for hepatocellular carcinoma (HCC) with no morphologic similarity to the gastric malignancy. This case highlights a rare finding of MPMTs. In addition to the diagnosis of a rare gastric malignancy, the patient developed a well-known but uncommon phenomenon of non-cirrhotic HCC associated with hepatitis C virus (HCV). Due to an increasing number of advances in cancer therapy that are leading to increased survival times, clinicians can expect for a patient to develop MPMTs in their lifetime. A high index of suspicion must exist for the possibility of MPMTs because treatment options and outcomes can be vastly affected by their findings.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Cureus Ano de publicação: 2022 Tipo de documento: Article